Skip to content

Evaluation of an Oral Care Programme for Head and Neck Cancer Patients

Evaluation of an Oral Care Programme for Patients Undergoing Treatment for Head and Neck Cancer Regarding Mucositis, Oral Health, Epigenetic Modifications, Patient-related Factors, Quality of Life and Health Economy

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03481647
Enrollment
150
Registered
2018-03-29
Start date
2018-01-08
Completion date
2026-12-31
Last updated
2025-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and Neck Cancer

Brief summary

This study will evaluate the effect of an intensified oral care programme on prevalence, severity and duration of mucositis in patients undergoing treatment for cancer in the head and neck region. Patients in the control group get professional oral care once a week.

Detailed description

This study will evaluate the effect of an oral care programme on prevalence, severity and duration of mucositis in patients undergoing treatment for cancer in the head and neck region. The oral care programme consists of professional oral care and swabbing of the mucosal membranes with a saline/bicarbonate solution once a week. The patients are instructed to rinse with a saline/bicarbonate solution 5 times per day. They are given an oral care diary to help them keep track of their daily oral hygiene measures and rinses. Repeated oral hygiene instructions are given if needed. Patients in the control group get professional oral care once a week.

Interventions

PROCEDUREOral care programme

Professional oral care (dental hygienist), intensified oral care measures by the patient

Sponsors

Ryhov County Hospital
CollaboratorOTHER
Region Jönköping County
CollaboratorOTHER_GOV
Swedish Cancer Foundation
CollaboratorOTHER
Kalmar County Hospital
CollaboratorOTHER
Norrlands University Hospital
CollaboratorOTHER
The Sjöberg Foundation
CollaboratorUNKNOWN
TUA research funding: The Sahlgrenska Academy/Region Västra Götaland
CollaboratorUNKNOWN
Malmö University
CollaboratorOTHER
Göteborg University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Masking description

The participants will not be aware of the care/treatment given to the other group

Intervention model description

Intervention group: intensified oral care programme Control group: conventional oral care

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients scheduled to receive full dose of curative RT including major salivary glands in the radiation field

Exclusion criteria

* Patients with recurrent cancer * Patients with severe cognitive impairment.

Design outcomes

Primary

MeasureTime frameDescription
Oral mucositisFirst week of RT (mucositis score at one time-point)Reduced incidence of clinical mucositis assessed using Oral Mucositis Assessment Scale (9 areas in the mouth are examined and signs of ulceration are scored; 0=no lesion,1= lesion \<1cm2, 2=lesion 1-3 cm2, 3=lesion \> 3 cm2 as well as erythema, which is scored as follows: 0=no erythema, 1= mild erythema and 2=severe erythema. Total score for ulceration can vary from 0-27 and for erythema from 0-18. Mucositis is present at scores ≥ 1.)

Countries

Sweden

Contacts

Primary ContactAnnica Almståhl, Assoc.prof
annica.almstahl@odontologi.gu.se+46317863208

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026